Overview

Trachoma Amelioration in Northern Amhara (TANA)

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The WHO has initiated a program to eliminate trachoma, blinding eye infection caused by Chlamydia trachomatis, in large part by mass distributions of oral azithromycin. The proposed study will determine the frequency and treatment target of community-wide mass antibiotic treatment. We will also study the impact of mass antibiotic distribution on antibiotic-resistance in pneumococcus.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
Azithromycin